PlainPharmaWatch

CMS Open Payments · Tool

Insmed, Inc. vs EMD Serono, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Insmed, Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 148, versus 58 for the other company. Its single largest recorded recipient represents 0.1% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Insmed, Inc.
HHI 148 · top recipient 0.1%
Ranked #1,628 of 1,838 companies by HHI
EMD Serono, Inc.
HHI 58 · top recipient 0.0%
Ranked #1,754 of 1,838 companies by HHI

Payment Overview

Company A

Insmed, Inc.

Total Payments
$12.0M
% of Industry
0.1%
Transactions
24,801
Avg per Transaction
$484.52
Recipients
13,950
Avg per Recipient
$861.40
Payment Types
6
Top Payment Type
Consulting Fee
Company B

EMD Serono, Inc.

Total Payments
$12.1M
% of Industry
0.1%
Transactions
34,399
Avg per Transaction
$352.14
Recipients
34,007
Avg per Recipient
$356.19
Payment Types
7
Top Payment Type
Compensation for Services Other Than Consulting

Highlighted values indicate the higher figure for each metric.

Total payments compared

Insmed, Inc. vs EMD Serono, Inc. - total reported payments in CMS Open Payments PY2024

EMD Serono, Inc.$12.1MInsmed, Inc.$12.0M

Payment Types Breakdown

Insmed, Inc.

Consulting Fee $603.1K

5.0%

Food and Beverage $302.0K

2.5%

Travel and Lodging $71.1K

0.6%

Grant $50.0K

0.4%

Space Rental or Facility Fees $31.3K

0.3%

Education $7.0K

0.1%

EMD Serono, Inc.

Compensation for Services Other Than Consulting $6.6M

54.9%

Consulting Fee $1.4M

11.7%

Food and Beverage $965.6K

8.0%

Travel and Lodging $804.8K

6.6%

Grant $109.0K

0.9%

Education $8.6K

0.1%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Insmed, Inc.

  1. 1

    National Jewish Health

    $56,000.00 · 3 txns

  2. 2

    Steven Zelenkofske

    $43,000.00 · 10 txns

  3. 3

    Wael EL MARAACHLI

    $34,092.66 · 29 txns

  4. 4

    Marianne Culkin Mann

    $34,050.00 · 3 txns

  5. 5

    Christopher J Richards

    $33,514.57 · 32 txns

EMD Serono, Inc.

  1. 1

    DONALD NEGROSKI

    $163,866.27 · 58 txns

  2. 2

    Cleveland Clinic Hospital

    $148,582.00 · 1 txns

  3. 3

    REGINA BERKOVICH

    $145,256.72 · 76 txns

  4. 4

    AUGUSTO MIRAVALLE

    $144,648.46 · 63 txns

  5. 5

    HEIDI CRAYTON

    $140,411.30 · 153 txns

Summary Comparison

Metric Insmed, Inc. EMD Serono, Inc.
Total Payments $12.0M $12.1M
% of Industry Total 0.1% 0.1%
Transaction Count 24,801 34,399
Avg per Transaction $484.52 $352.14
Recipient Count 13,950 34,007
Avg per Recipient $861.40 $356.19
Payment Type Count 6 7
Top Payment Type Consulting Fee Compensation for Services Other Than Consulting

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.